Dynepo Long-Term Safety Study

Summary

To assess the incidence rate of Treatment Emergent Adverse Events (TEAEs) over 2 years in patients treated with Dynepo.

Timeline

Start

2007-06-06

Primary completion

2008-07-31

Completion

2008-07-31

Outcome

Outcome not reported

Stopped: “The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA”

Drugs

Indications